Beauty Giants Target ‘Ozempic Face’ as Boom in Obesity Drugs Opens New Market
The companies are testing injectables and new products as clinics report rising demand for procedures that address facial volume loss after rapid weight loss.
- Swiss skincare firm Galderma, Brazilian cosmetics group Natura, and beauty giant L'Oréal are developing treatments for facial sagging and volume loss tied to the boom in obesity drugs.
- The obesity drug market could reach $150 billion in annual sales by 2030, while 53% of aesthetics clinics anticipate an influx of patients due to weight-loss medications.
- Consultant dermatologist Beibei Du-Harpur of King's College London said the term 'Ozempic face' is misleading, as facial volume loss stems from rapid weight loss rather than the drugs themselves.
- Galderma's Anne-Cecile Chevrier said 'sagginess is a concern,' while L'Oréal's Delphine Viguier-Hovasse confirmed the company is testing products on GLP-1 users in separate studies.
- Plastic surgeon Dr. Graeme Glass of British beauty brand LYMA cautioned that creams cannot alter the face's ligamental structure or reach the deep fat layer where volume loss occurs.
20 Articles
20 Articles
Rapid weight loss has changed people's needs, and cosmetic companies are now trying to create specific products to counteract certain side effects.
The expansion of GLP-1 receptor agonist drugs, known by some of their commercial versions, such as the Ozempic, is not only changing the bodies — more and more people are taking them to lose weight — but it is also beginning to have an impact on the industry. One of the most striking cases is cosmetics.
An emaciated, aged and slightly hollow appearance. These are signs of the new phenomenon "Ozempic face". Now several beauty giants are working to find treatments for the phenomenon.
Attentive to the new needs and concerns generated by the increasingly widespread use of LPG-1, the cosmetic industry tests products to counteract some of the adverse effects of these medicines
The dermatology group Galderma is growing strongly. Among other things, it benefits from treatments of the "Ozempic-Face".
The explosion of slimming drugs creates a new market for L’Oréal, Galderma and Natura, which are developing treatments for sagging and volume loss in the face - Experts point out limited effectiveness of cosmetics and need for scientific documentation
Coverage Details
Bias Distribution
- 47% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
